title: Filler frontier: what's new and heading West to the US market.
abstract: The amount of fillers approved by the United States Food and Drug Administration (FDA) for use in facial volume augmentation is diminutive in comparison to filler products employed worldwide. In the near future, several new hyaluronic acid filler products will be available to the United States market. Already approved fillers include Belotero Balance for fine lines, Juvéderm Voluma XC for midfacial volume loss replacement, and Restylane Silk for perioral lines and lip augmentation. Volbella, currently under FDA evaluation, will be used for fine-line correction and lip augmentation. The physiochemical properties, best practices, clinical uses, and side effects of these fillers are discussed. Additionally, evolving techniques such as the use of blunt-tipped microcannulas are explained.
authors.affiliation: Art of Skin MD, 437 S. Highway 101, Suite 217, Solana Beach, California 92075, USA. melanie.palm@gmail.com.
authors.forename: Melanie D
authors.initials: MD
authors.lastname: Palm
mesh_terms: D057785:Catheters; D003357:Cosmetic Techniques; D000067548:Dermal Fillers / Q000008:administration & dosage*; D004209:Disposable Equipment; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage
chemical_list: D000067548:Dermal Fillers; D006820:Hyaluronic Acid
keywords: fillers; hyaluronic acid